• Diseases
  • African Trypanosomiasis
  • Buruli Ulcer
  • Chagas Disease
  • Cholera
  • Dengue
  • Dracunculiasis
  • Emerging infectious diseases
  • Fascioliasis
  • Leishmaniasis
  • Leprosy
  • Lymphatic Filariasis
  • Malaria
  • Onchocerciasis
  • Schistosomiasis
  • Soil transmitted helminthiases
  • Trachoma
  • Tuberculosis
  • Yaws
  • Zoonoses
• Global health topics
  • Agriculture
  • Biotechnology
  • Climate change
  • Capacity building
  • Community health
  • Conflict
  • Diagnostics
  • Economics
  • Environment
  • Ethics
  • Equity
  • Funding
  • Gender
  • Health policy and systems
  • Human rights
  • Immunology
  • Innovation
  • Operations research
  • Pharmaceutical products
  • Poverty
  • Primary health care
  • Research priorities
  • Research translation
  • Social environment
  • Vaccines
  • Vectors
• News
• Reviews
• Editorial opinions
• Research articles
• Reports
• Virtual journals
• Profiles
• Policy & Strategy
• Funding opportunities
• Networking
• Resources
• Toolkits
  • Knowledge Translation (KT) Toolkit
  • Health Research Systems Analysis (HRSA) Toolkit

Communities of practice

• Disease Reference Groups
• Thematic Reference Groups

Divergent Goals and Commitments in Global Malaria Intervention

1 Oct 2008

Paul Chinnock

Source: PLoS Medicine (see original article)

Citation: Kiszewski AE (2008). Divergent Goals and Commitments in Global Malaria Intervention. PLoS Med 5(7): e159

2008 Anthony E. Kiszewski. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Commenting on a recent research article (1), which provided a comprehensive and rigorous analysis of global malaria financing, epidemiologist Anthony Kiszewski says the gap between planned expenditure and what is actually needed is so large that it is unlikely that international goals to reduce disease burdens will be achieved.

Dr Kiszewski points out that malaria is no longer considered to be a ‘neglected’ disease, because there have been major increases in the funding provided for control activities and for research. However, he continues, ‘The world invests only about $US1 billion per year, billions short of what several independent estimates suggest is necessary to achieve basic international goals for reducing malaria burdens’.

Target 8 of Goal 6 of the Millennium Development Goals is to have begun to reverse the incidence of malaria and other major diseases by 2015. Dr Kiszewski believes that it is unlikely that this target will be met unless further resource commitments can be made. The longer-term intention to eliminate malaria will also recede further into the distance.

The size of the gap revealed by the research on which Dr Kiszewski comments varies considerably between regions. However, he believes it is possible that the gap may be even wider than the analysis has shown.

Reference

1. Snow RW, Guerra CA, Mutheu JJ, Hay SI (2008). International funding of malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med 5: e142. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18651785.

Comments